Kimia Biosciences [KIMIABL] vs Innova Captab [INNOVACAP] Detailed Stock Comparison

Kimia Biosciences

BSE
Loading...

Innova Captab

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Kimia Biosciences wins in 3 metrics, Innova Captab wins in 8 metrics, with 0 ties. Innova Captab appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricKimia BiosciencesInnova CaptabBetter
P/E Ratio (TTM)N/A37.44N/A
Price-to-Book Ratio16.795.07Innova Captab
Debt-to-Equity Ratio394.9235.24Innova Captab
PEG RatioN/A7.14N/A
EV/EBITDA10.9426.94Kimia Biosciences
Profit Margin (TTM)7.31%9.98%Innova Captab
Operating Margin (TTM)6.75%11.68%Innova Captab
EBITDA Margin (TTM)6.75%11.68%Innova Captab
Return on EquityN/A13.37%N/A
Return on Assets (TTM)N/A8.12%N/A
Free Cash Flow (TTM)N/A$-1.09BN/A
1-Year Return-26.03%16.46%Innova Captab
Price-to-Sales Ratio (TTM)1.393.74Kimia Biosciences
Enterprise Value$2.06B$51.37BInnova Captab
EV/Revenue Ratio1.723.95Kimia Biosciences
Gross Profit Margin (TTM)N/A37.21%N/A
Revenue per Share (TTM)$26$227Innova Captab
Earnings per Share (Diluted)N/A$22.70N/A
Beta (Stock Volatility)0.97N/AN/A
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Kimia Biosciences vs Innova Captab Stock Performance Analysis

Loading Price Chart...

Kimia Biosciences
Innova Captab
Kimia Biosciences Stock Overview | Innova Captab Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Kimia Biosciences1.05%-0.96%1.90%-46.26%-6.31%-17.56%
Innova Captab0.35%0.46%-4.62%-2.11%-0.23%-24.99%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Kimia Biosciences-26.03%-18.52%17.43%84.95%84.95%84.95%
Innova Captab16.46%53.72%53.72%53.72%53.72%53.72%

News Based Sentiment: Kimia Biosciences vs Innova Captab

Kimia Biosciences

News based Sentiment: NEGATIVE

Kimia Biosciences experienced a significant decline in stock price and financial performance during the month of October 2025. The substantial drops in net sales and profit, combined with a high debt-to-equity ratio, create a concerning picture for investors. The closure of the trading window and AGM proceedings are standard corporate governance but don't offset the negative financial trends.

View Kimia Biosciences News Sentiment Analysis

Innova Captab

News based Sentiment: POSITIVE

Innova Captab reported impressive revenue and profit growth for both Q1 FY2026 and the full fiscal year 2025-26, supported by a 'Buy' rating from JM Financial. While there were shifts in shareholding, particularly a decrease in FII holdings, the overall narrative points towards a positive trajectory for the company.

View Innova Captab News Sentiment Analysis

Performance & Financial Health Analysis: Kimia Biosciences vs Innova Captab

MetricKIMIABLINNOVACAP
Market Information
Market Cap i₹1.75B₹48.64B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i5,54633,824
90 Day Avg. Volume i12,36840,665
Last Close₹37.38₹835.20
52 Week Range₹34.25 - ₹86.85₹662.00 - ₹1,260.00
% from 52W High-56.96%-33.71%
All-Time High₹86.85 (Jul 02, 2025)₹1,260.00 (Jan 06, 2025)
% from All-Time High-56.96%-33.71%
Growth Metrics
Quarterly Revenue Growth0.05%0.20%
Quarterly Earnings Growth-0.58%0.05%
Financial Health
Profit Margin (TTM) i0.07%0.10%
Operating Margin (TTM) i0.07%0.12%
Return on Equity (TTM) iN/A0.13%
Debt to Equity (MRQ) i394.9235.24
Cash & Liquidity
Book Value per Share (MRQ)₹2.11₹167.66
Cash per Share (MRQ)₹0.04₹11.41
Operating Cash Flow (TTM) i₹0₹282.88M
Levered Free Cash Flow (TTM) i₹0₹1.28B
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Kimia Biosciences vs Innova Captab

MetricKIMIABLINNOVACAP
Price Ratios
P/E Ratio (TTM) iN/A37.44
Forward P/E iN/A20.01
PEG Ratio iN/A7.14
Price to Sales (TTM) i1.393.74
Price to Book (MRQ) i16.795.07
Market Capitalization
Market Capitalization i₹1.75B₹48.64B
Enterprise Value i₹2.06B₹51.37B
Enterprise Value Metrics
Enterprise to Revenue i1.723.95
Enterprise to EBITDA i10.9426.94
Risk & Other Metrics
Beta i0.97N/A
Book Value per Share (MRQ) i₹2.11₹167.66

Financial Statements Comparison: Kimia Biosciences vs Innova Captab

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)KIMIABLINNOVACAP
Revenue/Sales iN/A₹3.52B
Cost of Goods Sold iN/A₹2.21B
Gross Profit iN/A₹1.31B
Research & Development iN/AN/A
Operating Income (EBIT) iN/A₹410.54M
EBITDA iN/A₹565.82M
Pre-Tax Income iN/A₹426.77M
Income Tax iN/A₹116.62M
Net Income (Profit) iN/A₹310.15M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)KIMIABLINNOVACAP
Cash & Equivalents iN/A₹155.19M
Total Current Assets iN/A₹7.03B
Total Current Liabilities iN/A₹3.53B
Long-Term Debt iN/A₹2.45B
Total Shareholders Equity iN/A₹9.59B
Retained Earnings iN/A₹4.53B
Property, Plant & Equipment iN/A₹442.93M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)KIMIABLINNOVACAP
Operating Cash Flow iN/A₹378.60M
Capital Expenditures iN/A₹-1.21B
Free Cash Flow iN/A₹-908.56M
Debt Repayment iN/A₹-7.69M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricKIMIABLINNOVACAP
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i5,54633,824
Average Daily Volume (90 Day) i12,36840,665
Shares Outstanding i47.31M57.22M
Float Shares i3.80M15.70M
% Held by Insiders i0.92%0.72%
% Held by Institutions i0.00%0.19%

Dividend Analysis & Yield Comparison: Kimia Biosciences vs Innova Captab

MetricKIMIABLINNOVACAP
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A